Page 39 - Delaware Medical Journal - July/August 2020

TREATMENT
CONTRIBUTORS
■ JONATHAN LI, MD is a resident physician of Combined Internal Medicine-Pediatrics at ChristianaCare and Nemours/Alfred I. duPont Hospital for Children interested in clinical immunology, environmental health, and advocacy.
■ SHALINI VADALIA, MD is a resident physician of Combined Internal Medicine-Pediatrics at ChristianaCare and Nemours/Alfred I. duPont Hospital for Children interested in global health, hospital medicine, and critical care medicine.
■ ELISSA MILLER, MD is Division Chief of Palliative Medicine at Nemours/Alfred I. duPont Hospital for Children; Clinical Assistant Professor of Pediatrics at Thomas Jefferson University; Fellow, American Academy of Pediatrics; Member, American Academy of Hospice and Palliative Medicine; and an invited lecturer and author of medical journal articles.
REFERENCES
1. Cohen SP, Bhatia A, Buvanendran A, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists: Reg Anesth Pain Med. June 2018:1. doi:10.1097/AAP.0000000000000808
2. Lubega FA, DeSilva MS, Munube D, et al. Low-Dose Ketamine Versus Morphine for Acute Severe Vaso Occlusive Pain in Children: A Randomized Controlled Trial. Scand J Pain. 2018;18(1):19-27. doi:10.1515/sjpain-2017-0140
3. Sheehy KA, Lippold C, Rice AL, Nobrega R, Finkel JC, Quezado ZM. Subanesthetic Ketamine for Pain Management in Hospitalized Children, Adolescents, and Young Adults: A Single-Center Cohort Study. J Pain Res. 2017;10:787-795. doi:10.2147/JPR.S131156
4. Franck LS, Harris SK, Soetenga DJ, Amling JK, Curley MAQ. The Withdrawal Assessment Tool-1 (WAT-1): An Assessment Instrument for Monitoring Opioid and Benzodiazepine Withdrawal Symptoms in Pediatric Patients. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2008;9(6):573-580. doi:10.1097/PCC.0b013e31818c8328
5. Brandow AM, Zappia KJ, Stucky CL. Sickle Cell Disease: A Natural Model of Acute and Chronic Pain. Pain. 2017;158 Suppl 1:S79-S84. doi:10.1097/j. pain.0000000000000824
6. Karafin MS, Chen G, Wandersee NJ, et al. Chronic Pain in Adults with Sickle Cell Disease Is Associated with Alterations in Functional Connectivity of the Brain. PloS One. 2019;14(5):e0216994. doi:10.1371/journal.pone.0216994
7. Dampier C, Palermo TM, Darbari DS, Hassell K, Smith W, Zempsky W. AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain. J Pain Off J Am Pain Soc. 2017;18(5):490-498. doi:10.1016/j.jpain.2016.12.016
8. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A Comprehensive Review of Opioid-Induced Hyperalgesia. Pain Physician. 2011;14(2):145-161.
9. Gao M, Rejaei D, Liu H. Ketamine Use in Current Clinical Practice. Acta Pharmacol Sin. 2016;37(7):865-872. doi:10.1038/aps.2016.5
10. Pham TH, Gardier AM. Fast-Acting Antidepressant Activity of Ketamine: Highlights on brain Serotonin, Glutamate, and GABA Neurotransmission in Preclinical Studies. Pharmacol Ther. 2019;199:58-90. doi:10.1016/j.pharmthera.2019.02.017
11. Koppert W, Sittl R, Scheuber K, Alsheimer M, Schmelz M, Schüttler J. Differential Modulation of Remifentanil-Induced Analgesia and Postinfusion Hyperalgesia by S-ketamine and Clonidine in Humans. Anesthesiology. 2003;99(1):152-159. doi:10.1097/00000542-200307000-00025
12. Laulin J-P, Maurette P, Corcuff J-B, Rivat C, Chauvin M, Simonnet G. The Role of Ketamine in Preventing Fentanyl-Induced Hyperalgesia and Subsequent Acute Morphine Tolerance. Anesth Analg. 2002;94(5):1263-1269, table of contents. doi:10.1097/00000539-200205000-00040
13. Graudins A, Meek R, Egerton-Warburton D, Oakley E, Seith R. The PICHFORK (Pain in Children Fentanyl or Ketamine) Trial: A Randomized, Controlled Trial Comparing Intranasal Ketamine and Fentanyl for the Relief of Moderate to Severe Pain in Children with Limb Injuries. Ann Emerg Med. 2015;65(3):248- 254.e1. doi:10.1016/j.annemergmed.2014.09.024
14. Tawfic QA, Faris AS, Kausalya R. The Role of a Low-Dose Ketamine-Midazolam Regimen in the Management of Severe Painful Crisis in Patients with Sickle Cell Disease. J Pain Symptom Manage. 2014;47(2):334-340. doi:10.1016/j.jpainsymman.2013.03.012
15. Neunhoeffer F, Hanser A, Esslinger M, et al. Ketamine Infusion as a Counter Measure for Opioid Tolerance in Mechanically Ventilated Children: A Pilot Study. Paediatr Drugs. 2017;19(3):259-265. doi:10.1007/s40272-017-0218-4
16. Quinlan J. The Use of a Subanesthetic Infusion of Intravenous Ketamine to Allow Withdrawal of Medically Prescribed Opioids in People with Chronic Pain, Opioid Tolerance and Hyperalgesia: Outcome at 6 Months: Table 1. Pain Med. 2012;13(11):1524-1525. doi:10.1111/j.1526-4637.2012.01486.x
17. Uprety D, Baber A, Foy M. Ketamine Infusion for Sickle Cell Pain Crisis Refractory to Opioids: A Case Report and Review of Literature. Ann Hematol. 2014;93(5):769-771. doi:10.1007/s00277-013-1954-3
18. Jennings CA, Bobb BT, Noreika DM, Coyne PJ. Oral Ketamine for Sickle Cell Crisis Pain Refractory to Opioids. J Pain Palliat Care Pharmacother. 2013;27(2):150-154. doi:10.3109/15360288.2013.788599
19. Winegarden J, Carr DB, Bradshaw YS. Intravenous Ketamine for Rapid Opioid Dose Reduction, Reversal of Opioid-Induced Neurotoxicity, and Pain Control in Terminal Care: Case Report and Literature Review. Pain Med Malden Mass. 2016;17(4):644-649. doi:10.1111/pme.12865
20. Ocker AC, Shah NB, Schwenk ES, Witkowski TA, Cohen MJ, Viscusi ER. Ketamine and Cognitive Behavioral Therapy for Rapid Opioid Tapering With Sustained Opioid Abstinence: A Case Report and 1-Year Follow-up. Pain Pract Off J World Inst Pain. August 2019. doi:10.1111/papr.12829
21. Strickler EM, Schwenk ES, Cohen MJ, Viscusi ER. Use of Ketamine in a Multimodal Analgesia Setting for Rapid Opioid Tapering in a Profoundly Opioid- Tolerant Patient: A Case Report. AA Pract. 2018;10(7):179-181. doi:10.1213/XAA.0000000000000653
22. Michelet D, Hilly J, Skhiri A, et al. Opioid-Sparing Effect of Ketamine in Children: A Meta-Analysis and Trial Sequential Analysis of Published Studies. Paediatr Drugs. 2016;18(6):421-433. doi:10.1007/s40272-016-0196-y
Del Med J | July/August 2020 | Vol. 92 | No. 4 183